Coram Healthcare Introduces Hemophilia Services Division; Company Establishes New Focus on Providing Quality Care and Services to Patients with Hemophilia
DENVER--(BUSINESS WIRE)--Nov. 4, 1999--Coram Healthcare (NYSE:CRH), a leading national provider of alternate site infusion therapies, today announced that it has introduced a new division, Coram Hemophilia Services, designed to support existing and future patients with hemophilia.
Coram Hemophilia Services, headquartered in Malvern, Pa., offers patients a broad range of products and services including the provision of oral medications, clinical monitoring, home nursing, case management, billing and reimbursement, patient education programs and delivery of hemophilia factor. In addition, Coram Hemophilia Services will provide several lifestyle services for patients with hemophilia such as a comprehensive clinical pathway to assist patients who are undergoing joint replacement and other orthopedic procedures as well as information on fertility options for HIV discordant couples.
Coram has been servicing patients with hemophilia and other bleeding disorders for more than 15 years. The Company has created several new management positions to head Coram Hemophilia Services. Among those appointed are: Eric Hill, vice president, hemophilia services; David Madeiros, director, program development; Larry Madeiros, director, patient advocacy; Jim Lane, director of sales; and Joanne Boyer, director of operations.
"It is Coram's clinical specialty programs that have enabled us to differentiate ourselves and demonstrate to customers and patients our ability to provide quality care focused on specific disease states. The introduction of Coram Hemophilia Services was designed to place greater emphasis on hemophilia patients and cater to their specific needs and lifestyles. We identified an opportunity in the marketplace and saw a need to service these patients with dedicated, quality care and services. Moreover, we determined that these patients could also benefit from certain lifestyle services that would empower them to lead independent and active lifestyles. Our ability to continue this focus and extend our expertise into the hemophilia area will provide payers and patients alike with enhanced products, services and care," said Joseph Smith, Coram's chief operating officer.
"We have assembled an experienced management team to head our new hemophilia division. The new senior management team brings over 130 years of combined, first-hand hemophilia disease management knowledge and expertise to Coram's new division. In addition, the Madeiros brothers, who have hemophilia, are devoted to creating a hemophilia services division for Coram that fosters individually oriented client services and quality care. We look forward to the contributions they will make to this division and to our organization," concluded Smith. |
